TickerFacts.

Mirum Pharmaceuticals, Inc. (MIRM): Revenue

Annual figures by period end, from SEC filings.

$521.31M
Year ended 2025-12-31
$618.07M
Trailing 12 months to 2026-06-30
+89.1%
3-year compound annual growth
2020-12-31: $02021-12-31: $19.14M2022-12-31: $77.06M2023-12-31: $186.37M2024-12-31: $336.89M2025-12-31: $521.31M$521.31M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$521.31M+54.7%2026-02-25, From 2025-01-01
2024-12-31$336.89M+80.8%2026-02-25, From 2024-01-01
2023-12-31$186.37M+141.8%2026-02-25, From 2023-01-01
2022-12-31$77.06M+302.7%2025-02-26, From 2022-01-01
2021-12-31$19.14Mn/a2024-03-15, From 2021-01-01
2020-12-31$0n/a2022-03-09, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Mirum Pharmaceuticals, Inc. (MIRM)2025-12-31$521.31M+54.7%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$502.08M+126.3%
HUTCHMED (China) Ltd (HCM)2025-12-31$548.51M-13.0%
Travere Therapeutics, Inc. (TVTX)2025-12-31$490.73M+110.5%
Organogenesis Holdings Inc. (ORGO)2025-12-31$564.17M+17.0%
Nature's Sunshine Products Inc (NATR)2025-12-31$480.14M+5.7%
Zai Lab Ltd (ZLAB)2025-12-31$457.18M+15.0%
Insmed Inc (INSM)2025-12-31$606.42M+66.7%
Opko Health, Inc. (OPK)2025-12-31$606.88M-14.9%

Compare MIRM, BBIO, HCM, TVTX side by side · Screen every company in Pharmaceutical Preparations ↗